SSc-ILD was diagnosed by a positive ANA, a high anti-topoisomerase I antibody titer, and severe cystic fibrotic changes with honeycombing on HRCT, which also followed expert consensus-based clinical algorithms [1,7,8]. The gene discussed is BTG3; the disease is systemic sclerosis.